LONDON, October 23, 2013 /PRNewswire/ --
Global healthcare company GSK reported Q3 results showing group sales growth
+1%, earnings per share +16% and strong cash generation which has enabled the
company to re-affirm its guidance for the full year.
In a video interview, CFO Simon Dingemans said the company was making good
progress on reshaping and restructuring its cost base and that GSK was now
seeing the benefit of savings in both in its operations and the transformed
He also said that the emerging markets side to the business made a strong
contribution to the whole, despite a sales decline in China which had been
impacted by the investigation into its business there.
The interview and transcript are available now on
MerchantCantos produces in-depth interviews, documentaries and webcasts with
senior company executives. If you would like to contact us, please email
email@example.com or phone +44(0)207-936-1352.
Help employers find you! Check out all the jobs and post your resume.